BPC 157 as prototype cytoprotective agent should also control blood vessel function, depending upon injury, perforated defect or vessel obstruction
Affecting nearly half of individuals with BD, MetS compounds the risk of cardiovascular disease, type 2 diabetes, and premature mortality, while also undermining psychiatric stability and cognitive functioning
Regulatory & compliance status Important regulatory information Not approved for human use Both peptides are investigational research chemicals
The product must be prescribed and administered by qualified practitioners who can screen for contraindications, monitor real-time hemodynamics, and intervene promptly should infusion-related adverse events arise
One step at a time, literally
In telophase, Cx43 aggregated at the membrane of the cleavage furrow